Metagenomics Market Growth | Global Analysis 2027

The metagenomics market was valued at US$ 165.8 million in 2018 and it is projected to reach US$ 314.3 million in 2027; it is expected to grow at a CAGR of 7.7% from 2019 to 2027.

Metagenomics can be defined as the study of the metagenome, which is collective genome of microorganisms. The microorganisms are collected from an environmental samples and the studies are conducted to provide information on the microbial diversity and ecology of a specific environment. The study of microorganism is conducted through the shotgun metagenomics technology/ technique which is used to extract the DNA from the environmental sample and sequence the small fragments. The metagenomic is the rising and vibrant field that has appropriated the tools used for standard genomics and applied for the study of the entire communities of microbes. This requires no need to isolate and culture the individual microbial species. The primary aim of the metagenomics is study and identify the genes and metabolic pathways present in the microbial species. The growth of the global metagenomics market is attributed to the increasing venture capital investments, advantages of metagenomics in biotechnology and industrial application of metagenomics. However, high capital cost of metagenomics is the major factor hindering the market growth.

The global metagenomics market is expected to witness substantial growth The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Global Metagenomics Market

Get more information on this report : Request Free Sample PDF

Market Insights

Advantages of Metagenomics in Biotechnology to Drive Global Metagenomics Market Growth

Metagenomic is a field that combines various important molecular technologies and enables scientists to investigate microorganisms more deeply. The technology enables to unlock the vast biotechnological potentials that are held inside the microorganisms. Metagenomics helps to identify microorganism irrespective of whether they can be cultured or not. The analysis can be done from the genomic data obtained directly from an environmental sample that provides information about the species existing and it also allow the extraction of information regarding the functionality of microbial communities in their natural habitat.

In addition, the metagenomics also holds the capabilities in the food and pharmaceutical industries. For instance, metagenomics can be useful for the identification of enzymes with desirable technological properties. This enables to relate the capable of catalyzing novel reactions which may be difficult or expensive to produce. Moreover, it enables to identify the functions under a wide range of environmental conditions encountered in food and pharmaceutical processing cycles including extreme conditions of temperature, pH, osmolarity and others.

Furthermore, the biotechnological applications from metagenomics is likely to foster by the pursuit of fundamental ecological studies and focused screens for bioprospecting. Metagenomics has contributed to the discovery of antibiotics and industrial enzymes from cultured microorganisms. For instance, the discovery of streptomycin and other bacterial antibiotics bounced from very basic studies of metagenomics. 

Therefore, owing to the advantages of the metagenomics for the application in biotechnologies are likely to boost the growth of the metagenomics market in the forecast years.

Product-Based Insights

In terms of product, the global metagenomics market is segmented into instruments & software and consumables. In 2018, the consumables segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.

Global Metagenomics Market, by Product – 2018 and 2027

Get more information on this report : Request Free Sample PDF

Application-Based Insights

In terms of application, the global metagenomics market is segmented into clinical diagnostic, drug discovery metagenomics and others. The clinical diagnostics segment held the largest share of the market in 2018 and the same segment is estimated to register the highest CAGR during the forecast period.

Strategic Insights

The global metagenomics market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Global Metagenomics Market – by Product

• Instruments & Software
• Consumables

Global Metagenomics Market – by Application

• Clinical Diagnostics
• Drug Discovery
• Others

Global Metagenomics Market – by Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East & Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South America and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Merck KGaA
• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Qiagen
• Bio-Rad Laboratories, Inc
• Perkinelmer Inc.
• Illumina Inc.
• F.Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies Ltd.
• Pacific Bioscience of California, Inc.